P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
8.71
+0.11 (1.28%)
Sep 15, 2025, 4:00 PM EDT - Market closed
P3 Health Partners Stock Forecast
Stock Price Forecast
The 3 analysts that cover P3 Health Partners stock have a consensus rating of "Strong Buy" and an average price target of $17.5, which forecasts a 100.92% increase in the stock price over the next year. The lowest target is $12.5 and the highest is $20.
Price Target: $17.5 (+100.92%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for P3 Health Partners stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Lake Street | Lake Street | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +129.62% | Aug 28, 2025 |
Lake Street | Lake Street | Strong Buy Maintains $50 → $20 | Strong Buy | Maintains | $50 → $20 | +129.62% | Apr 21, 2025 |
TD Cowen | TD Cowen | Hold Maintains $45 → $13 | Hold | Maintains | $45 → $13 | +43.51% | Nov 20, 2024 |
BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2024 |
Lake Street | Lake Street | Strong Buy Maintains $450 → $225 | Strong Buy | Maintains | $450 → $225 | +2,483.24% | Mar 14, 2024 |
Financial Forecast
Revenue This Year
1.46B
from 1.50B
Decreased by -2.76%
Revenue Next Year
1.60B
from 1.46B
Increased by 9.46%
EPS This Year
-17.40
from -54.06
EPS Next Year
-6.53
from -17.40
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 1.5B | 1.7B | |
Avg | 1.5B | 1.6B | |
Low | 1.4B | 1.5B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.5% | 19.4% | |
Avg | -2.8% | 9.5% | |
Low | -7.8% | 1.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -17.75 | -0.22 | |
Avg | -17.40 | -6.53 | |
Low | -16.87 | -12.34 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | |
Avg | - | - | |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.